Skip to main content
Erschienen in:

23.11.2020 | COVID-19 | Original Paper Zur Zeit gratis

The Associated Factors of Anxiety and Depressive Symptoms in COVID-19 Patients Hospitalized in Wuhan, China

verfasst von: Xueyi Li, Jun Tian, Qun Xu

Erschienen in: Psychiatric Quarterly | Ausgabe 3/2021

Einloggen, um Zugang zu erhalten

Abstract

This study was aimed to investigate the prevalence and factors associated with anxiety and depressive symptoms among hospitalized patients with COVID-19 during the epidemic outbreak in Wuhan, China. A total of 99 COVID-19 patients were recruited and completed the Hospital Anxiety and Depression Scale (HADS) and the modified Medical Research Council (mMRC) Scale. Results showed there was no significant difference in anxiety or depressive symptoms between male and female. Patients aged 46–60 years old had a higher ratio of both anxiety and depressive symptoms. Besides, patients whose hospital stays was longer than 14 days had a higher risk of depressive symptoms than those stays was less than 7 days. There was no significant difference in the correlation between level of dyspnea and the levels of anxiety or depressive symptoms. In conclusion, COVID-19 patients might have anxiety and depressive symptoms during hospitalization. Clinicians should pay attention to the middle age group and patients with longer hospital stays.
Literatur
2.
Zurück zum Zitat Han Q, Lin Q, Jin S, You L. Coronavirus 2019-nCoV: a brief perspective from the front line. J Infect. 2020;80:373–7.CrossRef Han Q, Lin Q, Jin S, You L. Coronavirus 2019-nCoV: a brief perspective from the front line. J Infect. 2020;80:373–7.CrossRef
3.
Zurück zum Zitat Rogers JP, Chesney E, Oliver D, Pollak TA, McGuire P, Fusar-Poli P, et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020;7:611–27.CrossRef Rogers JP, Chesney E, Oliver D, Pollak TA, McGuire P, Fusar-Poli P, et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020;7:611–27.CrossRef
4.
Zurück zum Zitat Xiang YT, Yang Y, Li W, Zhang L, Zhang Q, Cheung T, et al. Timely mental health care for the 2019 novel coronavirus outbreak is urgently needed. Lancet Psychiatry. 2020;7:228–9.CrossRef Xiang YT, Yang Y, Li W, Zhang L, Zhang Q, Cheung T, et al. Timely mental health care for the 2019 novel coronavirus outbreak is urgently needed. Lancet Psychiatry. 2020;7:228–9.CrossRef
5.
Zurück zum Zitat Brooks SK, Webster RK, Smith LE, Woodland L, Wessely S, Greenberg N, et al. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet. 2020;395:912–20.CrossRef Brooks SK, Webster RK, Smith LE, Woodland L, Wessely S, Greenberg N, et al. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet. 2020;395:912–20.CrossRef
6.
Zurück zum Zitat Greenberg N, Docherty M, Gnanapragasam S, Wessely S. Managing mental health challenges faced by healthcare workers during covid-19 pandemic. Bmj. 2020;368:m1211.CrossRef Greenberg N, Docherty M, Gnanapragasam S, Wessely S. Managing mental health challenges faced by healthcare workers during covid-19 pandemic. Bmj. 2020;368:m1211.CrossRef
7.
Zurück zum Zitat Asmundson GJG, Taylor S. Coronaphobia: fear and the 2019-nCoV outbreak. J Anxiety Disord. 2020;70:102196.CrossRef Asmundson GJG, Taylor S. Coronaphobia: fear and the 2019-nCoV outbreak. J Anxiety Disord. 2020;70:102196.CrossRef
8.
Zurück zum Zitat Parshall MB, Schwartzstein RM, Adams L, Banzett RB, Manning HL, Bourbeau J, et al. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med. 2012;185:435–52.CrossRef Parshall MB, Schwartzstein RM, Adams L, Banzett RB, Manning HL, Bourbeau J, et al. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med. 2012;185:435–52.CrossRef
9.
Zurück zum Zitat Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the hospital anxiety and depression scale. An updated literature review. J Psychosom Res. 2002;52:69–77.CrossRef Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the hospital anxiety and depression scale. An updated literature review. J Psychosom Res. 2002;52:69–77.CrossRef
10.
Zurück zum Zitat Yang Z, Huang X, Liu X, Hou J, Wu W, Song A, et al. Psychometric properties and factor structure of the Chinese version of the hospital anxiety and depression scale in people living with HIV. Front Psych. 2019;10:346.CrossRef Yang Z, Huang X, Liu X, Hou J, Wu W, Song A, et al. Psychometric properties and factor structure of the Chinese version of the hospital anxiety and depression scale in people living with HIV. Front Psych. 2019;10:346.CrossRef
11.
Zurück zum Zitat Norton S, Cosco T, Doyle F, Done J, Sacker A. The hospital anxiety and depression scale: a meta confirmatory factor analysis. J Psychosom Res. 2013;74:74–81.CrossRef Norton S, Cosco T, Doyle F, Done J, Sacker A. The hospital anxiety and depression scale: a meta confirmatory factor analysis. J Psychosom Res. 2013;74:74–81.CrossRef
12.
Zurück zum Zitat Altose MD. Assessment and management of breathlessness. Chest. 1985;88:77s–83s.CrossRef Altose MD. Assessment and management of breathlessness. Chest. 1985;88:77s–83s.CrossRef
13.
Zurück zum Zitat Paz-Diaz H, Montes de Oca M, Lopez JM, Celli BR. Pulmonary rehabilitation improves depression, anxiety, dyspnea and health status in patients with COPD. Am J Phys Med Rehabil. 2007;86:30–6.CrossRef Paz-Diaz H, Montes de Oca M, Lopez JM, Celli BR. Pulmonary rehabilitation improves depression, anxiety, dyspnea and health status in patients with COPD. Am J Phys Med Rehabil. 2007;86:30–6.CrossRef
14.
Zurück zum Zitat Kong X, Zheng, K, Tang M, Kong F, Zhou J, Diao L, et al. Prevalence and factors associated with depression and anxiety of hospitalized patients with COVID-19. medRxiv. 2020; 2020.2003.2024.20043075. Kong X, Zheng, K, Tang M, Kong F, Zhou J, Diao L, et al. Prevalence and factors associated with depression and anxiety of hospitalized patients with COVID-19. medRxiv. 2020; 2020.2003.2024.20043075.
15.
Zurück zum Zitat Wang Y, Di Y, Ye J, Wei W. Study on the public psychological states and its related factors during the outbreak of coronavirus disease 2019 (COVID-19) in some regions of China. Psychol Health Med. 2020:1–10. Wang Y, Di Y, Ye J, Wei W. Study on the public psychological states and its related factors during the outbreak of coronavirus disease 2019 (COVID-19) in some regions of China. Psychol Health Med. 2020:1–10.
16.
Zurück zum Zitat Gudmundsson G, Gislason T, Janson C, Lindberg E, Hallin R, Ulrik CS, et al. Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression. Eur Respir J. 2005;26:414–9.CrossRef Gudmundsson G, Gislason T, Janson C, Lindberg E, Hallin R, Ulrik CS, et al. Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression. Eur Respir J. 2005;26:414–9.CrossRef
17.
Zurück zum Zitat Yohannes AM, Baldwin RC, Connolly MJ. Depression and anxiety in elderly outpatients with chronic obstructive pulmonary disease: prevalence, and validation of the BASDEC screening questionnaire. Int J Geriatr Psychiatry. 2000;15:1090–6.CrossRef Yohannes AM, Baldwin RC, Connolly MJ. Depression and anxiety in elderly outpatients with chronic obstructive pulmonary disease: prevalence, and validation of the BASDEC screening questionnaire. Int J Geriatr Psychiatry. 2000;15:1090–6.CrossRef
18.
Zurück zum Zitat Yohannes AM, Junkes-Cunha M, Smith J, Vestbo J. Management of Dyspnea and Anxiety in chronic obstructive pulmonary disease: a critical review. J Am Med Dir Assoc. 2017;18:1096.e1091–17.CrossRef Yohannes AM, Junkes-Cunha M, Smith J, Vestbo J. Management of Dyspnea and Anxiety in chronic obstructive pulmonary disease: a critical review. J Am Med Dir Assoc. 2017;18:1096.e1091–17.CrossRef
19.
Zurück zum Zitat Chen T, Wu D, Chen H, Yan W, Yang D, Chen G, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. Bmj. 2020;368:m1091.CrossRef Chen T, Wu D, Chen H, Yan W, Yang D, Chen G, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. Bmj. 2020;368:m1091.CrossRef
20.
Zurück zum Zitat Papaioannou AI, Bartziokas K, Tsikrika S, Karakontaki F, Kastanakis E, Banya W, et al. The impact of depressive symptoms on recovery and outcome of hospitalised COPD exacerbations. Eur Respir J. 2013;41:815–23.CrossRef Papaioannou AI, Bartziokas K, Tsikrika S, Karakontaki F, Kastanakis E, Banya W, et al. The impact of depressive symptoms on recovery and outcome of hospitalised COPD exacerbations. Eur Respir J. 2013;41:815–23.CrossRef
21.
Zurück zum Zitat Schuler M, Wittmann M, Faller H, Schultz K. The interrelations among aspects of dyspnea and symptoms of depression in COPD patients - a network analysis. J Affect Disord. 2018;240:33–40.CrossRef Schuler M, Wittmann M, Faller H, Schultz K. The interrelations among aspects of dyspnea and symptoms of depression in COPD patients - a network analysis. J Affect Disord. 2018;240:33–40.CrossRef
Metadaten
Titel
The Associated Factors of Anxiety and Depressive Symptoms in COVID-19 Patients Hospitalized in Wuhan, China
verfasst von
Xueyi Li
Jun Tian
Qun Xu
Publikationsdatum
23.11.2020
Verlag
Springer US
Schlagwort
COVID-19
Erschienen in
Psychiatric Quarterly / Ausgabe 3/2021
Print ISSN: 0033-2720
Elektronische ISSN: 1573-6709
DOI
https://doi.org/10.1007/s11126-020-09865-9

Neu im Fachgebiet Psychiatrie

Digitale Therapie lindert Borderline-Persönlichkeitsstörung

Eine rein digitale Therapie ohne therapeutische Unterstützung kann die Symptomatik bei Borderline-Persönlichkeitsstörung bereits etwas lindern, auch scheint sie das Suizidrisiko zu mindern. Darauf deuten Ergebnisse einer großen kontrollierten Studie. Die Effekte sind aber eher gering.

Schadet Schichtarbeit dem Gehirn?

Eine große Registerstudie bestätigt, dass Schichtarbeit mit einem erhöhten Risiko für psychische und neurologische Erkrankungen einhergeht, sowie mit einer Volumenabnahme in Gehirnarealen, die für Depression, Angst und kognitive Funktionen relevant sind.

Starke Menopausensymptome: ein Hinweis auf kognitive Veränderungen?

Stärkere Beschwerden in der Perimenopause sind mit einer reduzierten kognitiven Funktion in den mittleren und späteren Lebensjahren assoziiert. Auch das Verhalten kann sich ändern, wie eine Studie zeigt. Beides steht womöglich für erhöhte Demenzgefährdung.

Was tun, wenn pneumologische Medikamente Psyche und Blutbild verändern?

Arzneimittel für Patienten mit Mukoviszidose oder pulmonaler arterieller Hypertonie wirken offenbar nicht nur auf die Lunge. Was es in der Praxis zu beachten gilt, wurde beim Pneumologie-Kongress erläutert.

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.